The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% | #gene therapy manufacturing # viral vector manufacturing # viral and non-viral vectors # vector manufacturing # Market Research # Market Insights

The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15%

Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors, offering lucrative opportunities to players having capabilities for in-house and contract manufacturing of various types of vectors.

The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% | #antibody Drug Conjugate # contract manufacturing organizations # ADC # ADC contract manufacturing # Market Research # Market Insights

The ADC contract manufacturing market is projected to grow at a CAGR of more than 13%

Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initiatives to become one-stop-shops to cater to the diverse needs of ADC developers.

The taste masking market is anticipated to grow at a steady pace till 2035 | #taste masking # taste assessment # taste masking and taste assessment techniques # taste masking market # Market Research # Market Insights

The taste masking market is anticipated to grow at a steady pace till 2035

Driven by the growing need to enhance palatability of oral drugs and drug adherence among pediatric and geriatric population, the demand for novel and advanced taste masking and taste assessment technologies is expected to rise in the coming years.

The adeno-associated viral vector market is anticipated to grow at a CAGR of more than 10% by 2035 | #adeno-Associated Viral Vector Market # adeno viral vector # AAV vector # adeno-associated vector # Market Research # Market Insights

The adeno-associated viral vector market is anticipated to grow at a CAGR of more than 10% by 2035

Given their low immunogenicity, diversified targets and ability to offer higher biosafety, the adeno-associated viral vectors are actively being evaluated for the development of various therapies for the treatment of chronic diseases and infections.

The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% | #blood csf barrier # Blood-Brain Barrier # CNS drugs # central nervous system # Market Research # Market Insights

The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12%

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems.